Your browser doesn't support javascript.
loading
Antioxidative and anti-inflammatory activity of psiguadial B and its halogenated analogues as potential neuroprotective agents.
Man Kadayat, Tara; Eun Kim, Dong; Bong Lee, Sang; Jung, Kyungjin; Eun Park, Sang; Hong, Ji-Ye; Kim, Jina; Shrestha, Aarajana; Kim, Dong-Su; An, Hongchan; Kim, Nayeon; Lee, Su-Jeong; Kwon, Sugyeong; Kim, Suhui; Yeon Hwang, Jun; Kim, Shinae; Hahn, Dongyup; Choi, Hyukjae; Nam, Sang-Jip; Hyun Jeon, Yong; Jin Hwang, Jung; Jin Cho, Sung; Chin, Jungwook.
Afiliação
  • Man Kadayat T; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Eun Kim D; Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Bong Lee S; Vaccine Commercialization Center, Gyeongbuk Institute for Bio Industry, Andong 33618, Republic of Korea.
  • Jung K; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Eun Park S; Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Hong JY; Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
  • Kim J; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Shrestha A; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Kim DS; Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, 34114 Daejeon, Republic of Korea.
  • An H; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Kim N; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Lee SJ; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Kwon S; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Kim S; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Yeon Hwang J; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Kim S; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Hahn D; School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Choi H; College of Pharmacy, Yeungnam University, Gyeongbuk 38541, Republic of Korea.
  • Nam SJ; Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Hyun Jeon Y; Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
  • Jin Hwang J; Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea; Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea. Electronic address: jjhwang@amc.seoul.kr.
  • Jin Cho S; Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea. Electronic address: sjcho@kist.re.kr.
  • Chin J; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea. Electronic address: jwchin@dgmif.re.kr.
Bioorg Chem ; 113: 105027, 2021 08.
Article em En | MEDLINE | ID: mdl-34098398

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terpenos / Fármacos Neuroprotetores / Anti-Inflamatórios / Antioxidantes Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terpenos / Fármacos Neuroprotetores / Anti-Inflamatórios / Antioxidantes Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article